Physician profile
Ramsey K Majzoub
NPI 1235188863
$1,338.68
in general payments reported to CMS, 2019-2025
15 companies · $294 in 2025
The $294 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $309 · 2020: $15.23 · 2022: $53.47 · 2023: $313 · 2024: $354 · 2025: $294.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $801 · Long Term Medical Supply Or Device Loan: $159.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $801.31 |
| Long Term Medical Supply Or Device Loan | $159.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $529.12 | 2019-2025 | Grafix Pl, Stravix, Oasis |
| Integra Lifesciences Corporation | $294.31 | 2019-2025 | Cytal, Integra, Primatrix |
| Organogenesis INC. | $111.13 | 2019-2024 | Puraply |
| Kerecis Limited | $97.72 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Polymedics Innovations INC. | $58.04 | 2023 | |
| Bsn Medical INC | $53.47 | 2022 | |
| Tei Biosciences INC | $34.23 | 2019 | |
| Avita Medical Americas, LLC | $28.81 | 2024 | |
| Reprise Biomedical, INC. | $28.20 | 2024 | Miro3d |
| Solventum Corporation | $24.32 | 2025 | Activ.A.C. |
| Paratek Pharmaceuticals, INC. | $18.69 | 2024 | Nuzyra |
| Clinical Technology, INC | $15.87 | 2025 | Pain Management |
| Aroa Biosurgery Incorporated | $15.47 | 2023 | |
| Melinta Therapeutics, LLC | $14.66 | 2019 | |
| Tactile Systems Technology INC | $14.64 | 2025 | Nimbl, Flexitouch Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramsey Majzoub listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.